Related by context. All words. (Click for frequent words.) 70 chorioamnionitis 68 perinatal outcomes 68 singleton pregnancy 68 perimenopausal women 68 gestational hypertension 67 preterm deliveries 67 preeclamptic 67 singleton pregnancies 67 recurrent miscarriage 67 Postmenopausal 66 urolithiasis 66 VLBW 66 Complication rates 66 nadroparin 66 polycystic ovary syndrome PCOS 66 subclinical hypothyroidism 66 nonpregnant women 66 nulliparous 66 drank pomegranate juice 66 neurodevelopmental outcomes 66 undergone hysterectomy 66 nonobese 66 Cesarean deliveries 65 monozygotic twin 65 anovulatory 65 neurodevelopmental impairment 65 transfusion syndrome 65 LNG IUS 65 retrospective cohort 65 ELBW infants 65 parous women 65 breastfed exclusively 65 recurrent UTI 65 uncomplicated pregnancies 65 serum lipid levels 65 undergoing bariatric surgery 65 parous 65 nonvertebral fractures 65 endometrial carcinoma 65 nondepressed 65 % CI #.#-#.# [003] 65 hip BMD 64 T1DM 64 nondiabetic patients 64 normotensive 64 ovulatory cycles 64 adenotonsillectomy 64 VLBW infants 64 perinatal complications 64 antiretroviral naïve 64 birthweight babies 64 % CI #.#-#.# [008] 64 femoral neck BMD 64 spontaneous vaginal 64 thromboembolic complications 64 HIV uninfected 64 caesarean section births 64 irregular menstrual periods 64 GH deficiency 64 serum IGF 64 gestational diabetes mellitus GDM 64 overt hypothyroidism 64 follicular phase 64 serum estradiol 63 postnatally 63 relapsed MM 63 Caesarean deliveries 63 Juvenile Idiopathic Arthritis 63 underwent bariatric surgery 63 carotid atherosclerosis 63 underwent CABG 63 gestational diabetes mellitus 63 normal birthweight 63 inhaled budesonide 63 irregular menstrual cycles 63 neurologic complications 63 liver transplant recipients 63 Gestational 63 VADT 63 thrombophilia 63 DHEA supplementation 63 colorectal adenoma 63 recurrent VTE 63 Baseline characteristics 63 epidural analgesia 63 undergone radical prostatectomy 63 neurodevelopmental outcome 63 HIV HCV coinfected 63 Neonates 63 seropositivity 63 irregular menses 63 obese postmenopausal 63 prepubertal 63 undergone hysterectomies 63 Heterozygous Familial Hypercholesterolemia 63 anal incontinence 63 nonobese patients 63 Heavy menstrual bleeding 62 asymptomatic hypothyroidism 62 Wistar rats 62 underwent liver transplantation 62 #q# deletion syndrome 62 intraventricular hemorrhage 62 GnRH agonist 62 spine BMD 62 antenatal depression 62 multivariable adjusted 62 undergoing radical prostatectomy 62 pre pubertal 62 multivariate analyzes 62 premenopausal 62 antenatal corticosteroids 62 odds ratios ORs 62 thromboprophylaxis 62 persistent pulmonary hypertension 62 recurrent wheeze 62 waist circumferences 62 Polycystic Ovary Syndrome 62 morphometric vertebral fractures 62 tumor histology 62 recurrent venous thromboembolism 62 limiting generalizability 62 MMSE scores 62 postoperative mortality 62 prospective cohort 62 artery calcification 62 pre eclamptic 62 bivariate analyzes 62 MetS 62 ductal breast cancer 62 psychiatric comorbidities 62 CHD mortality 62 habitual snoring 62 Multicenter AIDS 62 ICSI cycles 62 Premenopausal women 62 corifollitropin alfa 62 elective Caesarean 62 Subgroup analyzes 62 LHRH receptor positive 62 euthyroid 62 Breastfed infants 62 multicentre prospective 62 Univariate analysis 62 ovariectomy 62 perioperatively 62 operable breast cancer 62 % CI #.#-#.# [007] 62 nonpregnant 62 myelomeningocele 62 GBA mutations 62 osteopenic 62 undescended testes 62 perioperative complications 62 BMI z 62 fasting triglyceride levels 62 corticosteroid induced 62 juvenile idiopathic arthritis JIA 62 tertiles 62 insecurely attached 62 multivariable analyzes 62 Stent thrombosis 62 coronary calcification 62 born preterm 62 oxycodone CR 62 Subgroup analysis 62 Preterm infants 62 amenorrhoea 62 adverse perinatal 61 plasma homocysteine levels 61 adjunctive placebo 61 thyroid hormone levels 61 prepregnancy BMI 61 adenoidectomy 61 HIV seronegative 61 transaminase elevations 61 CYP#D# inhibitor 61 CVD mortality 61 acetabular dysplasia 61 endometrial hyperplasia 61 atypical hyperplasia 61 PGD PGS 61 leiomyomas 61 bilateral oophorectomy 61 recurrent wheezing 61 obstetric complications 61 peritoneal cancer 61 posttreatment 61 vaginal hysterectomy 61 comorbid illnesses 61 onset diabetes mellitus 61 vertebral fracture 61 nonvertebral fracture 61 longitudinal cohort study 61 IM progesterone 61 polycystic ovarian syndrome PCOS 61 hsCRP levels 61 CI #.#-#.# [001] 61 conjugated equine estrogen 61 venous thromboembolic disease 61 hormone therapy HT 61 systolic hypertension 61 underwent radical prostatectomy 61 CARDIA study 61 fetal malformations 61 overactive bladder symptoms 61 thrombocytopenic 61 dysfunctional voiding 61 Gestational age 61 cardiac malformations 61 peripartum 61 Flu Cy 61 pyelonephritis 61 beta blocker therapy 61 % CI #.#-#.# [006] 61 hypopituitarism 61 femoral neck fractures 61 varicoceles 61 hemodynamically significant 61 vesicoureteral reflux 61 handgrip strength 61 placental malaria 61 abdominal ultrasounds 61 retrograde ejaculation 61 anovulatory infertility 61 IVF ICSI 61 RYGB surgery 61 flutamide 61 recurrent miscarriages 61 undergone bariatric surgery 61 hypertension diabetes mellitus 61 mild gestational diabetes 61 undergoing peritoneal dialysis 61 Apgar scores 61 morbidly obese adolescents 61 tertile 61 elective cesarean delivery 61 monozygotic 61 nondemented 61 precancerous cervical 61 deep venous thromboses 61 confidence interval #.#-#.# 61 hMG 61 nonmetastatic 61 depressive symptomatology 61 Comorbidities 61 alendronate Fosamax 61 congenital toxoplasmosis 61 comorbid conditions 61 BMI ≥ 60 spontaneous preterm delivery 60 posttransplant 60 THIS STUDY 60 dietary calcium intake 60 visceral metastases 60 decompensated liver disease 60 placebo controlled clinical 60 CYPHER Stent 60 serum calcium levels 60 androgen suppression 60 aortic atherosclerosis 60 preterm newborns 60 Dietary Modification Trial 60 lobular breast cancer 60 breastfed infants 60 hypertensive disorders 60 baseline HbA1c 60 mammographic density 60 polytherapy 60 caesarean deliveries 60 PHPT 60 breech births 60 REYATAZ ritonavir 60 euthymic patients 60 congenital abnormalities 60 WHIMS 60 retrospective cohort study 60 thyrotropin levels 60 multiple logistic regression 60 nonfasting triglyceride levels 60 trials RCTs 60 carotid artery stenting CAS 60 postoperative pulmonary 60 gastroesophageal reflux GERD 60 polycystic ovaries 60 nondiabetic 60 aged ≥ 60 prospective observational 60 exposed prenatally 60 pancreatic resection 60 URTI 60 postoperative AF 60 undergo bariatric surgery 60 unexplained stillbirth 60 perioperative morbidity 60 pyridostigmine 60 Legg Calvé Perthes disease 60 venlafaxine XR 60 AMOR IPAT 60 T1c 60 chronic prostatitis 60 detrusor overactivity 60 prepregnancy 60 elective caesarean section 60 hormone therapy estrogen 60 hypothalamic amenorrhea 60 PPCM 60 CC genotype 60 hypogonadal men 60 delivered vaginally 60 CARDIA 60 salpingo oophorectomy 60 menstrual irregularity 60 prolactin elevation 60 histologically confirmed 60 dyspareunia 60 intrapartum 60 androgen deprivation 60 subtrochanteric 60 postmenopausal hormones 60 bronchopulmonary dysplasia 60 beta carotene supplementation 60 intima media thickness 60 #mg BID [001] 60 postintervention 60 IUGR 60 underwent resection 60 anovulation 60 comorbid disorders 60 de novo AML 60 preterm neonates 60 ovulatory 60 pyloric stenosis 60 Framingham Offspring 60 perioperative mortality 60 venlafaxine Effexor 60 singleton babies 60 GH deficient 60 hypoglycaemic episodes 60 symptomatic VTE 60 histologically proven 60 relapsed ALL 60 secondary amenorrhea 60 β blockers 60 intractable epilepsy 60 familial aggregation 60 diagnosed prenatally 60 postmenopausal hormone therapy 60 menstrual abnormalities 60 Preoperatively 60 affective psychosis 60 multivariable analysis 60 orofacial clefts 60 Depressive symptoms 60 endocrine responsive 60 premenstrual syndrome PMS 60 peripartum cardiomyopathy 60 rFSH 60 COPD exacerbation 60 serum uric acid 60 echocardiographic parameters 60 PLMs 60 peri menopausal women 60 Health Initiative Observational 60 advanced adenoma 60 cryptorchidism 60 BRCA2 mutation carriers 60 initiating antiretroviral therapy 60 shorter telomere length 60 singleton births 59 loop diuretics 59 CIMZIA TM certolizumab pegol 59 paroxetine Paxil 59 Insulin sensitivity 59 Male infertility 59 LUTS 59 orchitis 59 logistic regression analysis 59 polyp recurrence 59 AGILECT R 59 REYATAZ r arm 59 clomipramine 59 delaying childbearing 59 postpartum haemorrhage 59 ALT flares 59 Avandia Actos 59 Uterine cancer 59 patients undergoing CABG 59 low birthweights 59 severe mitral regurgitation 59 hyperemesis gravidarum 59 paroxysmal AF 59 HRQL 59 pulmonary hypoplasia 59 IDDM 59 Premature infants 59 multivariate logistic regression 59 diabetes mellitus DM 59 comorbid depression 59 nontraumatic 59 VUR 59 atypical neuroleptics 59 Metastatic Prostate Cancer 59 acid suppressive medications 59 juvenile idiopathic arthritis 59 glycated hemoglobin levels 59 P = .# 59 sociodemographic characteristics 59 reflux symptoms 59 dizygotic 59 ginkgo biloba extract 59 prospective longitudinal 59 NPH insulin 59 TEAEs 59 genital ulcer disease 59 folate supplementation 59 Henrik Leffers 59 TT genotype 59 aromatase inhibitor therapy 59 undergoing hysterectomy 59 Lipodystrophy 59 BRCA testing 59 nephrolithiasis 59 HIV seropositive 59 Preterm 59 oligohydramnios 59 unexplained infertility 59 woman ovulates 59 tibolone 59 chronic periodontitis 59 interquartile range 59 #mg/day [001] 59 PLX STROKE targeting 59 autistic traits 59 timepoints 59 fibroids endometriosis 59 Cholesterol Levels SPARCL 59 oral antidiabetic medication 59 Digital Mammographic Imaging 59 daily subcutaneous injections 59 caesarean delivery 59 abnormal lipid levels 59 postoperative complication 59 methotrexate therapy 59 attention-deficit/hyperactivity disorder ADHD 59 lung resections 59 lipid lowering agents 59 stepwise logistic regression 59 monozygotic twins 59 decompensated cirrhosis 59 longitudinal observational study 59 National Birth Cohort 59 chlamydial infection 59 lipid elevations 59 asymptomatic PAD 59 prospective multicenter study 59 hyperinsulinemic 59 seroconverted 59 BMD measurements 59 finasteride Proscar 59 #q#.# deletion syndrome 59 hormone FSH 59 hormone receptor negative 59 preintervention 59 obese adolescents 59 Polycystic ovary syndrome PCOS 59 plasma folate 59 HBeAg negative 59 Framingham Offspring Study 59 postmenopausal osteoporotic women 59 umbilical hernias 59 Thal Dex 59 acromegalic patients 59 endometriosis ovarian cysts 59 FDA defined valvulopathy 59 elevated ALT 59 pelvic prolapse 59 estrogen progestin therapy 59 HIV lipodystrophy 59 congenital CMV 59 CLINICAL STUDIES 59 delaying childbirth 59 pelvic lymphadenectomy 59 MenACWY 59 depot medroxyprogesterone acetate 59 neurodevelopmental disability 59 neurocognitive deficits 59 coinfection 59 prostate cancer CaP 59 clomiphene citrate 59 postmenopausal 59 pulmonary dysfunction 59 univariate analyzes 59 APOE genotype 59 postoperative delirium 59 neurological sequelae 59 subanalysis 59 TMC# r 59 carotid IMT 59 androgen ablation 59 carotid plaques 59 Generalized Anxiety Disorder 59 NATRECOR ® 59 Schaffir 59 undergoing liver transplantation 59 membrane rupture 59 placenta praevia 59 virologic failure 59 truncal 59 mild renal insufficiency 59 varicocele 59 paclitaxel eluting stents 59 symptomatic fibroids 59 highest tertile 59 endometrial thickness 59 PRADAXA #mg 59 penile vaginal intercourse 59 gallstone disease 59 Patency 59 CR nPR 59 everolimus eluting stents 59 angiographically 59 heFH 59 umol L 59 MMSE score 59 spontaneous preterm birth 59 VCUG 59 vaginal hysterectomies 59 serum concentrations 59 receiving XGEVA 59 autonomic dysfunction 59 vaginal childbirth 59 nocturnal hypoglycemia 59 undergoing CABG 59 LYSTEDA 58 adiponectin concentrations 58 distal radial fractures 58 Nonalcoholic Fatty Liver Disease 58 abnormal glucose tolerance 58 prospective observational cohort 58 acute cholecystitis 58 NHANES III 58 TKAs 58 untreated celiac disease 58 pelvic girdle pain 58 testosterone supplementation 58 multicenter randomized controlled 58 TDF FTC 58 BRCA1 mutations 58 definite stent thrombosis 58 lowest tertile 58 gestations 58 dysglycemia 58 recurrent metastatic 58 newer antipsychotics 58 systolic dysfunction 58 BRCA2 carriers 58 postmenopausal women 58 comorbidities 58 calcaneal fractures 58 psoriatic arthritis PsA 58 preterm infant 58 basal cell nevus syndrome 58 EDSS scores 58 observational cohort study 58 syncopal 58 male Sprague Dawley 58 malignant neoplasm 58 dosing cohort 58 nondiabetics 58 mg/m2 dose 58 fructose intolerance 58 dysmenorrhoea 58 Progestin 58 immunocompetent 58 prospectively enrolled 58 atopic disease 58 leptin deficient mice 58 norethindrone acetate 58 proliferative retinopathy 58 logistic regression analyzes 58 puerperal psychosis 58 abacavir Ziagen 58 HbA 1c levels 58 polycystic ovary syndrome 58 Munk Olsen 58 antihypertensive therapy 58 preserved ejection fraction 58 congenital malformations 58 Morbidly obese patients 58 BYSTOLIC 58 infliximab Remicade 58 IELT 58 adenoma recurrence 58 randomized multicenter trial 58 % CI #.#-#.# [004] 58 postoperative infections 58 spontaneous preterm births 58 biochemical relapse 58 observational cohort 58 STRIDE PD 58 hypospadias 58 undescended testicles 58 diastolic blood pressures 58 Postpartum depression affects 58 Hematologic 58 plasma homocysteine 58 PASI scores 58 Wisconsin Sleep Cohort 58 hyperbilirubinemia 58 intra articular injection 58 dysmenorrhea 58 Premenopausal 58 NNRTI resistance 58 dose paroxetine mesylate 58 Breastfed babies 58 BRCA1 mutation carriers 58 postmenopausal hormone replacement 58 Sexually active 58 epididymitis 58 opioid dependent 58 lopinavir r arm 58 Menopausal hormone therapy 58 locoregional recurrence 58 sacral nerve stimulation 58 citalopram Celexa 58 antidiabetic medication 58 gross hematuria 58 knee osteoarthritis OA 58 menstrual irregularities 58 metabolizer 58 latent celiac disease 58 GnRH agonists 58 oophorectomy 58 transferrin saturation 58 cranial irradiation 58 prospectively evaluated 58 Meta analyzes 58 PSA nadir 58 BRCA mutation carriers 58 nonsignificant difference 58 antibiotic prophylaxis 58 coinfected 58 BoNTA 58 OAB symptoms 58 postmenopausal hormone 58 hypercholesterolemic patients 58 pretransplant 58 HbA1C levels 58 knee OA 58 antireflux surgery 58 quetiapine risperidone 58 clodronate 58 serum urate levels 58 intrauterine fetal 58 atrophic gastritis 58 recurrent DVT 58 tipranavir r 58 aneuploidy screening 58 cranial radiation 58 opioid naive 58 Coronary Artery Bypass Graft 58 abnormal Pap smear 58 CIN3 58 triplet pregnancies 58 testicular tumors 58 terbutaline 58 nonvertebral 58 seronegative 58 Postmenopausal hormone therapy 58 SHBG levels 58 Preterm babies 58 drug eluting stent implantation 58 polycystic ovarian syndrome 58 nonoperative treatment 58 certolizumab 58 SORT OUT III 58 brachial plexus palsy 58 SIDS infants 58 noncardiac 58 triacylglycerol concentrations 58 recurrent acute pancreatitis 58 nonsevere 58 femoral neck fracture 58 androgen excess 58 multivitamin supplementation 58 onset idiopathic hypogonadism 58 facial clefts 58 sleeve lobectomy 58 idiopathic scoliosis 58 posttraumatic arthritis 58 weekly subcutaneous injections 58 RET PTC rearrangements 58 affective disorders 58 Post partum 58 neurosensory 58 levonorgestrel releasing 58 solifenacin 58 moderate renal impairment 58 subfertility 58 autistic regression 58 proband 58 lumbar spine BMD 58 elevated serum creatinine 58 comparator arm 58 amenorrhea 58 Postoperatively 58 prospectively randomized 58 nonischemic 58 premenopause 58 abnormal Pap test 58 HRQOL 58 untreated hypothyroidism 58 amisulpride 58 recurrent tonsillitis 58 Chlamydia infection 58 transaminase levels 58 antiretroviral naive 58 surgically induced 58 corrected QT interval 58 multicenter randomized placebo controlled 58 % CI #.#-#.# [005] 58 hyperlipidemic 58 HYVET 58 liver biopsies 58 newer antipsychotic medications 58 bladder exstrophy 58 hyperlipidemia hypertension 58 SRBD 58 advanced neoplasia 58 neurologic outcomes 58 histological subtype 58 ABC/3TC 58 osteosarcomas 58 nonexposed 58 postoperative infection 58 extrapyramidal symptoms 58 painful menstrual periods 58 Symptom severity 58 telomere lengths 58 genotypic resistance 58 psychiatric comorbidity 58 dimensional ultrasonography 58 osteoporotic vertebral compression fractures 58 hypofractionated radiation 58 advanced adenomas 58 ELBW 58 oral contraceptive pills 58 fragility fracture 58 atrioventricular block 58 ATACAND 58 q#h 58 aneurysmal subarachnoid hemorrhage 58 graft occlusion 58 abdominal hysterectomy 58 sFlt 1 58 Tonsillectomy 58 Swedish Mammography Cohort 58 nasopharyngitis headache 58 Thromboembolism 58 primary hypercholesterolemia 58 BRCA gene mutations 58 hematological parameters 58 hydroxyvitamin D levels 58 Moderate drinkers 58 hepatorenal syndrome 58 overactive bladder syndrome 58 external genital lesions 58 Arch Intern Med 58 ibandronate 58 recurrent atrial fibrillation 58 uninfected infants 58 fibroma 58 CAVEATS 58 genital abnormalities 58 VTE prophylaxis 58 elevated triglyceride levels 58 CYP#D# genotype 58 carotid stenosis 58 neonates 58 macrosomia 57 covariate 57 salmeterol fluticasone 57 psychiatric outpatients 57 adolescent females 57 tibiofemoral 57 reoperations 57 FeNO 57 PAP smears 57 neonatal encephalopathy 57 serum folate 57 Gestational diabetes affects 57 Randomized controlled 57 hours postdose 57 Femara letrozole 57 #Gy 57 multiple gestations 57 labral tears 57 oestradiol 57 intermittent exotropia 57 Folate deficiency 57 PREZISTA r arm 57 NMIBC 57 adrenalectomy 57 precocious puberty 57 Severe Primary IGFD 57 congenital anomalies 57 periodontal gum disease 57 onset atrial fibrillation 57 fluoxetine Prozac 57 depressive symptoms 57 cinacalcet 57 logistic regression model 57 heavy menstrual bleeding 57 Carotid Stenting 57 histologic subtype 57 laparoscopically assisted 57 invasive candidiasis 57 postpartum hemorrhage 57 2D 4D ratio 57 quadrivalent HPV vaccine 57 mL/min/#.# m 2 57 Sociodemographic 57 oocyte retrieval 57 zidovudine lamivudine 57 perfusion defects 57 Naive Patients 57 pCR 57 elevated CRP 57 antidiabetic medications 57 mIU L 57 progesterone receptor negative 57 Ovary removal 57 vitreous floaters 57 atopic 57 subgroup analyzes 57 ejection fractions 57 albumin excretion 57 pT2 57 esophageal reflux 57 biochemical recurrence 57 myometrium 57 tenofovir emtricitabine 57 fetal chromosomal 57 induce ovulation 57 neurocognitive impairment 57 luteal phase 57 â ‰ ¥ 57 LV dysfunction 57 colorectal neoplasia 57 dizygotic twins 57 de novo kidney transplant 57 vitamin D inadequacy 57 post thrombotic syndrome 57 Fosamax alendronate 57 aromatase inhibitors AIs 57 anticoagulants blood thinners 57 lignan intake 57 nodal metastasis 57 azoospermia 57 abdominal circumference 57 mcg BID 57 leucopenia 57 BLLs 57 perimenopausal 57 adiponectin levels 57 sonographic examinations 57 APOE ε4 57 gadolinium enhanced 57 lipid lowering drugs 57 hemoglobin A1c levels 57 virological failure 57 neoplasias 57 efavirenz EFV 57 interferon ribavirin 57 atopic asthma 57 atherosclerotic renal artery stenosis 57 underwent surgical resection 57 peri menopausal 57 untreated OSA 57 norgestimate 57 intracranial stenosis 57 #mmHg [001] 57 stage IIIb IV 57 oral clefts 57 postmenopause 57 CI -#.# 57 Aortic stenosis 57 psychiatric morbidity 57 NNT = 57 chlamydia infections 57 elevated LDH 57 abnormal uterine bleeding 57 Acute Myeloid Leukaemia AML 57 placebo controlled trials 57 adjuvant tamoxifen 57 testicular germ cell 57 aripiprazole Abilify 57 salivary cortisol 57 Perthes disease 57 bupropion SR 57 Cardiovascular Risk 57 primary aldosteronism 57 Preterm births 57 somatization disorder 57 thiazide diuretics 57 premenopausal breast cancer 57 premenopausal women 57 baseline LDH 57 ipsilateral stroke 57 gallbladder disease 57 MIRAPEX 57 conditional logistic regression 57 Intervention Trial 57 serologic testing 57 cerebral microbleeds 57 vascular dysfunction 57 Index CDAI 57 placebo dummy pill 57 severe hypoglycaemia 57 tolterodine ER 57 APTIVUS r 57 serum creatinine levels 57 laboratory abnormalities 57 meta regression 57 infertility miscarriage 57 typical antipsychotics 57 Postoperative complications 57 corticosteroid therapy 57 bronchopulmonary dysplasia BPD 57 Osteoporotic Fractures 57 primary ovarian insufficiency 57 C. trachomatis 57 generalized epilepsy 57 hematopoietic cancers 57 micronutrient supplementation 57 comorbid ADHD 57 serum phosphate 57 Myocardial infarction 57 estradiol gel indicated 57 Vitro fertilization 57 abnormal Pap smears 57 hypercalciuria 57 multivariable Cox 57 CLBP 57 coronary revascularization 57 nevirapine Viramune 57 chemoradiation therapy 57 iNO 57 Eclampsia 57 sacrocolpopexy 57 dyslipidaemia 57 comorbid anxiety 57 unsupplemented 57 divalproex sodium 57 risperidone Risperdal 57 systolic blood pressures 57 BARACLUDE ® 57 pretest probability 57 prescribed statins 57 lipid lowering therapy 57 adrenal function 57 retrospective observational study 57 folic acid supplement 57 eosinophilic asthma 57 CHDs 57 thromboses 57 underwent coronary angiography 57 tamoxifen Nolvadex ® 57 estimated GFR 57 randomized controlled trials RCTs 57 intratympanic 57 lobular cancer 57 attain statistical significance 57 utero exposure 57 neutrophil counts 57 lymphatic cancers 57 menopausal symptom 57 neurocognitive function 57 cystectomy 57 preoperative PSA 57 sociodemographic factors 57 undergoing coronary angiography 57 GOUT 57 polyhydramnios 57 macrovascular disease 57 steroid dexamethasone 57 hypogonadotropic hypogonadism 57 RLS symptoms 57 breast endometrial 57 pharmacokinetic interaction 57 perinatally 57 irregular ovulation 57 confidence interval CI 57 pamidronate 57 multicentre study 57 BPS IC 57 severe exacerbations 57 ß blockers